Singapore markets closed

Fulcrum Therapeutics, Inc. (FULC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.55-0.24 (-3.14%)
At close: 04:00PM EDT
7.50 -0.05 (-0.66%)
After hours: 06:25PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-99,426
-97,335
-109,871
-80,847
-70,819
Depreciation & amortisation
2,085
2,172
2,414
2,515
2,379
Stock-based compensation
14,465
14,802
13,350
11,070
7,350
Change in working capital
-3,471
-4,613
-3,094
-11,889
7,503
Accounts receivable
-
0
2,500
-500
-2,000
Accounts payable
159
-853
-1,176
973
1,773
Other working capital
-92,498
-91,473
-99,013
-80,191
-54,997
Other non-cash items
-
-
-
-
-2,000
Net cash provided by operating activities
-92,133
-90,965
-97,050
-78,478
-53,655
Cash flows from investing activities
Investments in property, plant and equipment
-365
-508
-1,963
-1,713
-1,342
Purchases of investments
-124,204
-194,892
-151,153
-216,234
-124,270
Sales/maturities of investments
219,946
158,708
165,529
88,278
68,474
Net cash used for investing activities
95,377
-36,692
12,413
-129,669
-57,138
Cash flows from financing activities
Debt repayment
-
-
0
-18
-50
Common stock issued
0
117,345
80,804
182,857
69,946
Common stock repurchased
-
-
-
-
-193
Other financing activities
-
-
-
-
-193
Net cash used provided by (used for) financing activities
2,080
118,122
84,323
186,507
71,132
Net change in cash
5,324
-9,535
-314
-21,640
-39,661
Cash at beginning of period
35,826
36,190
36,504
58,144
97,805
Cash at end of period
41,150
26,655
36,190
36,504
58,144
Free cash flow
Operating cash flow
-92,133
-90,965
-97,050
-78,478
-53,655
Capital expenditure
-365
-508
-1,963
-1,713
-1,342
Free cash flow
-92,498
-91,473
-99,013
-80,191
-54,997